Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-01-15

FDA Approved: MYFORTIC — Supplemental Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved a supplemental application for Myfortic (mycophenolic acid) submitted by Novartis Pharmaceuticals Corporation. The approval typically involves labe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MYFORTIC (MYCOPHENOLIC ACID)

Snippet

SUPPL AP for MYFORTIC (MYCOPHENOLIC ACID)